These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 16584728

  • 1. Long lasting heat shock stimulation of TRAIL-induced apoptosis in transformed T lymphocytes.
    Moulin M, Arrigo AP.
    Exp Cell Res; 2006 Jun 10; 312(10):1765-84. PubMed ID: 16584728
    [Abstract] [Full Text] [Related]

  • 2. IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC.
    Ramaswamy M, Efimova EV, Martinez O, Mulherkar NU, Singh SP, Prabhakar BS.
    Oncogene; 2004 Aug 12; 23(36):6083-94. PubMed ID: 15208670
    [Abstract] [Full Text] [Related]

  • 3. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
    Lawrence CP, Chow SC.
    FEBS Lett; 2005 Nov 21; 579(28):6465-72. PubMed ID: 16289096
    [Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects.
    Baader E, Toloczko A, Fuchs U, Schmid I, Beltinger C, Ehrhardt H, Debatin KM, Jeremias I.
    Cancer Res; 2005 Sep 01; 65(17):7888-95. PubMed ID: 16140959
    [Abstract] [Full Text] [Related]

  • 5. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW, Shah S.
    Asia Pac J Clin Nutr; 2005 Sep 01; 14(4):366-73. PubMed ID: 16326643
    [Abstract] [Full Text] [Related]

  • 6. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
    Hesry V, Piquet-Pellorce C, Travert M, Donaghy L, Jégou B, Patard JJ, Guillaudeux T.
    Prostate; 2006 Jun 15; 66(9):987-95. PubMed ID: 16541419
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
    Zhang L, Fang B.
    Cancer Gene Ther; 2005 Mar 15; 12(3):228-37. PubMed ID: 15550937
    [Abstract] [Full Text] [Related]

  • 8. Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP.
    Kang J, Bu J, Hao Y, Chen F.
    Prostate Cancer Prostatic Dis; 2005 Mar 15; 8(3):274-9. PubMed ID: 15897917
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.
    MacFarlane M, Harper N, Snowden RT, Dyer MJ, Barnett GA, Pringle JH, Cohen GM.
    Oncogene; 2002 Oct 03; 21(44):6809-18. PubMed ID: 12360407
    [Abstract] [Full Text] [Related]

  • 10. Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5.
    Horak P, Pils D, Kaider A, Pinter A, Elandt K, Sax C, Zielinski CC, Horvat R, Zeillinger R, Reinthaller A, Krainer M.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8585-91. PubMed ID: 16361541
    [Abstract] [Full Text] [Related]

  • 11. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
    Rubinchik S, Yu H, Woraratanadharm J, Voelkel-Johnson C, Norris JS, Dong JY.
    Cancer Gene Ther; 2003 Nov 15; 10(11):814-22. PubMed ID: 14605667
    [Abstract] [Full Text] [Related]

  • 12. A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteins.
    Miyazaki T, Reed JC.
    Nat Immunol; 2001 Jun 15; 2(6):493-500. PubMed ID: 11376335
    [Abstract] [Full Text] [Related]

  • 13. Time sequence of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and cisplatin treatment is responsible for a complex pattern of synergistic cytotoxicity.
    Kim YH, Lee YJ.
    J Cell Biochem; 2006 Aug 01; 98(5):1284-95. PubMed ID: 16514644
    [Abstract] [Full Text] [Related]

  • 14. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.
    Ou D, Wang X, Metzger DL, Robbins M, Huang J, Jobin C, Chantler JK, James RF, Pozzilli P, Tingle AJ.
    Hum Immunol; 2005 Jul 01; 66(7):799-809. PubMed ID: 16112027
    [Abstract] [Full Text] [Related]

  • 15. The TRAIL DISCussion: It is FADD and caspase-8!
    Peter ME.
    Cell Death Differ; 2000 Sep 01; 7(9):759-60. PubMed ID: 11042670
    [No Abstract] [Full Text] [Related]

  • 16. Oncogenic Ras sensitizes normal human cells to tumor necrosis factor-alpha-related apoptosis-inducing ligand-induced apoptosis.
    Nesterov A, Nikrad M, Johnson T, Kraft AS.
    Cancer Res; 2004 Jun 01; 64(11):3922-7. PubMed ID: 15173003
    [Abstract] [Full Text] [Related]

  • 17. Dimethyl sulfoxide potentiates death receptor-mediated apoptosis in the human myeloid leukemia U937 cell line through enhancement of mitochondrial membrane depolarization.
    Vondrácek J, Soucek K, Sheard MA, Chramostová K, Andrysík Z, Hofmanová J, Kozubík A.
    Leuk Res; 2006 Jan 01; 30(1):81-9. PubMed ID: 15998540
    [Abstract] [Full Text] [Related]

  • 18. Cyclooxygenase-2 inhibition sensitizes human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating death-inducing signaling complex components into ceramide-enriched caveolae.
    Martin S, Phillips DC, Szekely-Szucs K, Elghazi L, Desmots F, Houghton JA.
    Cancer Res; 2005 Dec 15; 65(24):11447-58. PubMed ID: 16357153
    [Abstract] [Full Text] [Related]

  • 19. TRAIL-induced apoptosis in U-1242 MG glioma cells.
    Saqr HE, Omran OM, Oblinger JL, Yates AJ.
    J Neuropathol Exp Neurol; 2006 Feb 15; 65(2):152-61. PubMed ID: 16462206
    [Abstract] [Full Text] [Related]

  • 20. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
    Poulaki V, Mitsiades CS, McMullan C, Fanourakis G, Negri J, Goudopoulou A, Halikias IX, Voutsinas G, Tseleni-Balafouta S, Miller JW, Mitsiades N.
    Invest Ophthalmol Vis Sci; 2005 Jan 15; 46(1):358-66. PubMed ID: 15623796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.